433 related articles for article (PubMed ID: 22704962)
1. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
Boissier MC; Semerano L; Challal S; Saidenberg-Kermanac'h N; Falgarone G
J Autoimmun; 2012 Sep; 39(3):222-8. PubMed ID: 22704962
[TBL] [Abstract][Full Text] [Related]
2. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune arthritis: the interface between the immune system and joints.
Komatsu N; Takayanagi H
Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
[TBL] [Abstract][Full Text] [Related]
4. Preferential accumulation of activated Th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints.
Yamada H; Nakashima Y; Okazaki K; Mawatari T; Fukushi J; Oyamada A; Fujimura K; Iwamoto Y; Yoshikai Y
J Rheumatol; 2011 Aug; 38(8):1569-75. PubMed ID: 21532055
[TBL] [Abstract][Full Text] [Related]
5. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
[TBL] [Abstract][Full Text] [Related]
6. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Dec; 7(2):137-42. PubMed ID: 18035324
[TBL] [Abstract][Full Text] [Related]
7. Cell and cytokine imbalances in rheumatoid synovitis.
Boissier MC
Joint Bone Spine; 2011 May; 78(3):230-4. PubMed ID: 20961791
[TBL] [Abstract][Full Text] [Related]
8. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
10. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
12. [Pathological mechanisms in rheumatoid arthritis].
Tanaka Y
Nihon Rinsho; 2013 Jul; 71(7):1147-52. PubMed ID: 23961659
[TBL] [Abstract][Full Text] [Related]
13. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
14. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
Szodoray P; Alex P; Dandapani V; Nakken B; Pesina J; Kim X; Wallis GL; Wilson PC; Jonsson R; Centola M
Scand J Immunol; 2004; 60(1-2):209-18. PubMed ID: 15238091
[TBL] [Abstract][Full Text] [Related]
18. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of rheumatoid arthritis. A critical assessment of the role of autologous stimulation in the perpetuation of rheumatoid synovitis.
Firestein GS; Zvaifler NJ
Rheum Dis Clin North Am; 1987 Dec; 13(3):447-61. PubMed ID: 3324200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
